| 摘要 |
<p>The invention relates to the use of a sex hormone (in particular estradiol on its own or with noresthisterone combined with methyl cyclodextrine) to obtain a pharmaceutical composition that is suitable for nasal administration in order to treat undesirable uterine bleeding phenomena in women.</p> |
